UPDATE 4-Possis tumbles after disappointing heart trial
17944
Shares of Possis Medical Inc. (POSS.O: Quote, Profile, Research) tumbled as much as 41 percent on Tuesday after the company cut its earnings outlook due to
451154
A drug approved last year as a last-ditch hope for some lung cancer patients who didn&#39;t find relief from other forms of therapy has come up short in a large clinical trial.
278955
Shares of subprime lender tumble after margin calls.
463333
AstraZeneca faced its third major setback in as many months yesterday after clinical trials dashed expectations that its lung cancer drug Iressa would develop into a blockbuster product that would dominate treatment around the world.
187448
Australia&#39;s S&amp;P/ASX 200 Index fell for a third day. Origin Energy Ltd. declined after New Zealand&#39;s Contact Energy Ltd.
426995
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down more than 8 percent.
561901
A disappointing study of the heart drug Vytorin has led some doctors to reconsider what makes statin drugs so effective at fighting heart disease.
24944
Europe's main stock exchanges slid on Tuesday, with London dragged downwards by a weak trading update from retailer Tesco, and as investors awaited fresh US earnings news.
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
756760
Decode Genetics Inc. said on Thursday  it was halting its late-stage clinical trial program for an  experimental oral heart attack drug after a formulation problem  with the tablets cropped up.
393367
A May trial run for the U.K.'s e-voting and e-counting systems resulted in crashed machines, confused tech-support staff, and raised concerns about security and reliability, according to a report released by a watchdog group.
55009
Disappointing trial data regarding the AngioJet catheter takes a 38% bite out of Possis Medical's stock.
193849
The price of shares in on-line gambling website Sportingbet have tumbled 41 percent when trading in the stock was resumed after suspension last week owing to the arrest of the company's chairman.
747288
Leading shares ended lower after a thinly-traded session tracking falls on Wall Street with investors cautious ahead of the Federal Reserve's latest US interest rate decision due after the London close tonight.
37828
A clinical trial of the blockbuster arthritis drug Celebrex was shut down yesterday after researchers found an increase in the risk of serious heart disease and strokes in those taking the
535410
Shares of Possis Medical Inc. fell more than 28 percent before the market open Tuesday, on news that it had cut its revenue outlook due to the poor performance of its AngioJet blood clot device in clinical trials.
548270
The findings of the 'American-Australian-African trial with DronedarONe In atrial fibrillation or flutter patients for the maintenance of Sinus rhythm' (ADONIS) trial, announced at the annual meeting of the ...